Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL
- Lupin received USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL
- It offers an alternative administration option for adults requiring anticoagulation therapy
- Tentative US approval may support Lupin’s product pipeline and future sales